EXPLANATORY NOTE
The XBRL interactive data file included as an exhibit to this filing relates to the Supplement dated March 16, 2020 to the GMO Trust Prospectus, dated June 30, 2019, as supplemented, filed with the Securities and Exchange Commission on March 16, 2020 (SEC Accession No. 0001104659-20-033922) pursuant to Rule 497(e) under the Securities Act of 1933, as amended.
EXHIBIT INDEX
GMO TRUST
Exhibit Ref. |
Title of Exhibit
|
EX-101/CAL | XBRL Taxonomy Extension Calculation Linkbase |
EX-101.DEF | XBRL Taxonomy Extension Definition Linkbase |
EX-101.INS | XBRL Instance Document |
EX-101.LAB | XBRL Taxonomy Extension Labels Linkbase |
EX-101.PRE | XBRL Taxonomy Extension Presentation Linkbase |
EX-101.SCH | XBRL Taxonomy Extension Schema Document |
Total | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GMO Emerging Country Debt Fund | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
GMO Emerging Country Debt Fund | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
GMO TRUST Supplement dated March 16, 2020 to the GMO Trust Prospectus, dated June 30, 2019, as supplemented GMO Emerging Country Debt Fund Effective March 16, 2020, the GMO Emerging Country Debt Fund (the “Fund”) charges a purchase premium of 1.15% of the amount invested and a redemption fee of 1.15% of the amount redeemed. The sections captioned “Shareholder fees” and “Example” on page 86 of the Prospectus are replaced with the following: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shareholder fees (fees paid directly from your investment) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Example | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
This example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The example assumes that you invest $10,000 in the Fund for the time periods indicated. The example also assumes that your investment has a 5% return each year and that the Fund's operating expenses remain the same as those shown in the table. The one year amounts shown reflect the expense waiver noted in the expense table. Although your actual costs may be higher or lower, based on these assumptions your costs would be: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Effective March 16, 2020, the “Average Annual Total Returns” table on page 89 of the Prospectus is replaced with the following: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Annual Total Returns Periods Ending December 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Label | Element | Value |
---|---|---|
GMO Emerging Country Debt Fund | ||
Risk/Return: | rr_RiskReturnAbstract | |
Supplement to Prospectus [Text Block] | rr_SupplementToProspectusTextBlock | GMO TRUST Supplement dated March 16, 2020 to the GMO Trust Prospectus, dated June 30, 2019, as supplemented GMO Emerging Country Debt Fund Effective March 16, 2020, the GMO Emerging Country Debt Fund (the “Fund”) charges a purchase premium of 1.15% of the amount invested and a redemption fee of 1.15% of the amount redeemed. The sections captioned “Shareholder fees” and “Example” on page 86 of the Prospectus are replaced with the following: |
Risk/Return [Heading] | rr_RiskReturnHeading | GMO Emerging Country Debt Fund |
Shareholder Fees Caption [Text] | rr_ShareholderFeesCaption | Shareholder fees (fees paid directly from your investment) |
Expense Example [Heading] | rr_ExpenseExampleHeading | Example |
Expense Example Narrative [Text Block] | rr_ExpenseExampleNarrativeTextBlock | This example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The example assumes that you invest $10,000 in the Fund for the time periods indicated. The example also assumes that your investment has a 5% return each year and that the Fund's operating expenses remain the same as those shown in the table. The one year amounts shown reflect the expense waiver noted in the expense table. Although your actual costs may be higher or lower, based on these assumptions your costs would be: |
Performance Narrative [Text Block] | rr_PerformanceNarrativeTextBlock | Effective March 16, 2020, the “Average Annual Total Returns” table on page 89 of the Prospectus is replaced with the following: |
Performance Table Heading | rr_PerformanceTableHeading | Average Annual Total Returns Periods Ending December 31, 2018 |
Index No Deduction for Fees, Expenses, Taxes [Text] | rr_IndexNoDeductionForFeesExpensesTaxes | (reflects no deduction for fees, expenses, or taxes) |
GMO Emerging Country Debt Fund | Class III | ||
Risk/Return: | rr_RiskReturnAbstract | |
Purchase premium (as a percentage of amount invested) | rr_MaximumDeferredSalesChargeOverOfferingPrice | 1.15% |
Redemption fee (as a percentage of amount redeemed) | rr_RedemptionFeeOverRedemption | 1.15% |
Expense Example, with Redemption, 1 Year | rr_ExpenseExampleYear01 | $ 288 |
Expense Example, with Redemption, 3 Years | rr_ExpenseExampleYear03 | 418 |
Expense Example, with Redemption, 5 Years | rr_ExpenseExampleYear05 | 559 |
Expense Example, with Redemption, 10 Years | rr_ExpenseExampleYear10 | 971 |
Expense Example, No Redemption, 1 Year | rr_ExpenseExampleNoRedemptionYear01 | 170 |
Expense Example, No Redemption, 3 Years | rr_ExpenseExampleNoRedemptionYear03 | 288 |
Expense Example, No Redemption, 5 Years | rr_ExpenseExampleNoRedemptionYear05 | 418 |
Expense Example, No Redemption, 10 Years | rr_ExpenseExampleNoRedemptionYear10 | $ 795 |
1 Year | rr_AverageAnnualReturnYear01 | (8.06%) |
5 Years | rr_AverageAnnualReturnYear05 | 4.53% |
10 Years | rr_AverageAnnualReturnYear10 | 12.23% |
Incept. | rr_AverageAnnualReturnSinceInception | 13.61% |
Inception Date | rr_AverageAnnualReturnInceptionDate | Apr. 19, 1994 |
GMO Emerging Country Debt Fund | Class III | After Taxes on Distributions | ||
Risk/Return: | rr_RiskReturnAbstract | |
1 Year | rr_AverageAnnualReturnYear01 | (10.78%) |
5 Years | rr_AverageAnnualReturnYear05 | 1.28% |
10 Years | rr_AverageAnnualReturnYear10 | 8.74% |
Incept. | rr_AverageAnnualReturnSinceInception | 8.47% |
Inception Date | rr_AverageAnnualReturnInceptionDate | Apr. 19, 1994 |
GMO Emerging Country Debt Fund | Class III | After Taxes on Distributions and Sale of Fund Shares | ||
Risk/Return: | rr_RiskReturnAbstract | |
1 Year | rr_AverageAnnualReturnYear01 | (4.75%) |
5 Years | rr_AverageAnnualReturnYear05 | 2.00% |
10 Years | rr_AverageAnnualReturnYear10 | 8.38% |
Incept. | rr_AverageAnnualReturnSinceInception | 8.62% |
Inception Date | rr_AverageAnnualReturnInceptionDate | Apr. 19, 1994 |
GMO Emerging Country Debt Fund | Class III | J.P. Morgan EMBI Global (Fund benchmark as of 6/30/19) (reflects no deduction for fees, expenses, or taxes) | ||
Risk/Return: | rr_RiskReturnAbstract | |
1 Year | rr_AverageAnnualReturnYear01 | (4.61%) |
5 Years | rr_AverageAnnualReturnYear05 | 4.19% |
10 Years | rr_AverageAnnualReturnYear10 | 7.79% |
Incept. | rr_AverageAnnualReturnSinceInception | 9.73% |
Inception Date | rr_AverageAnnualReturnInceptionDate | Apr. 19, 1994 |
GMO Emerging Country Debt Fund | Class III | J.P. Morgan EMBI Global + (Composite index) | ||
Risk/Return: | rr_RiskReturnAbstract | |
1 Year | rr_AverageAnnualReturnYear01 | (4.61%) |
5 Years | rr_AverageAnnualReturnYear05 | 4.19% |
10 Years | rr_AverageAnnualReturnYear10 | 7.79% |
Incept. | rr_AverageAnnualReturnSinceInception | 9.67% |
Inception Date | rr_AverageAnnualReturnInceptionDate | Apr. 19, 1994 |
GMO Emerging Country Debt Fund | Class IV | ||
Risk/Return: | rr_RiskReturnAbstract | |
Purchase premium (as a percentage of amount invested) | rr_MaximumDeferredSalesChargeOverOfferingPrice | 1.15% |
Redemption fee (as a percentage of amount redeemed) | rr_RedemptionFeeOverRedemption | 1.15% |
Expense Example, with Redemption, 1 Year | rr_ExpenseExampleYear01 | $ 283 |
Expense Example, with Redemption, 3 Years | rr_ExpenseExampleYear03 | 402 |
Expense Example, with Redemption, 5 Years | rr_ExpenseExampleYear05 | 532 |
Expense Example, with Redemption, 10 Years | rr_ExpenseExampleYear10 | 912 |
Expense Example, No Redemption, 1 Year | rr_ExpenseExampleNoRedemptionYear01 | 165 |
Expense Example, No Redemption, 3 Years | rr_ExpenseExampleNoRedemptionYear03 | 273 |
Expense Example, No Redemption, 5 Years | rr_ExpenseExampleNoRedemptionYear05 | 390 |
Expense Example, No Redemption, 10 Years | rr_ExpenseExampleNoRedemptionYear10 | $ 735 |
1 Year | rr_AverageAnnualReturnYear01 | (8.03%) |
5 Years | rr_AverageAnnualReturnYear05 | 4.59% |
10 Years | rr_AverageAnnualReturnYear10 | 12.30% |
Incept. | rr_AverageAnnualReturnSinceInception | 10.51% |
Inception Date | rr_AverageAnnualReturnInceptionDate | Jan. 09, 1998 |
GMO Emerging Country Debt Fund | Class IV | J.P. Morgan EMBI Global (Fund benchmark as of 6/30/19) (reflects no deduction for fees, expenses, or taxes) | ||
Risk/Return: | rr_RiskReturnAbstract | |
1 Year | rr_AverageAnnualReturnYear01 | (4.61%) |
5 Years | rr_AverageAnnualReturnYear05 | 4.19% |
10 Years | rr_AverageAnnualReturnYear10 | 7.79% |
Incept. | rr_AverageAnnualReturnSinceInception | 8.02% |
Inception Date | rr_AverageAnnualReturnInceptionDate | Jan. 09, 1998 |
GMO Emerging Country Debt Fund | Class IV | J.P. Morgan EMBI Global + (Composite index) | ||
Risk/Return: | rr_RiskReturnAbstract | |
1 Year | rr_AverageAnnualReturnYear01 | (4.61%) |
5 Years | rr_AverageAnnualReturnYear05 | 4.19% |
10 Years | rr_AverageAnnualReturnYear10 | 7.79% |
Incept. | rr_AverageAnnualReturnSinceInception | 7.96% |
Inception Date | rr_AverageAnnualReturnInceptionDate | Jan. 09, 1998 |
Document and Entity Information |
Total |
---|---|
Prospectus: | |
Document Type | 497 |
Document Period End Date | Mar. 16, 2020 |
Registrant Name | GMO TRUST |
Entity Central Index Key | 0000772129 |
Entity Inv Company Type | N-1A |
Amendment Flag | false |
Document Creation Date | Mar. 16, 2020 |
Document Effective Date | Mar. 16, 2020 |
Prospectus Date | Jun. 30, 2019 |
GMO Emerging Country Debt Fund | Class III | |
Prospectus: | |
Trading Symbol | GMCDX |
GMO Emerging Country Debt Fund | Class IV | |
Prospectus: | |
Trading Symbol | GMDFX |
T/ 3$#X^G3W,V QEJ3U>GE%]C6;F9K?JB^RY%:?&F>(-;]057F;*Y+;OR"J#D=&;ARG0+
M6_4%X*3 0X"MG9R/G
MS;,3,5WLKLCM]<6SH/?FZ8F85NBMTFXI06E_)E("\DNOTUS[6$W0:\0*Y9-]
M']MUS%T^:6+Y;HG#*<"U*\I:B^J,0DIB)D=5EE"\5E208LQ_A=@&"2"80]S3
M%D'FTTQCA S9I[@:?U]L[BG"U&2M:[9S%AW7AUV09<$YE47+Z#)7K9\6K..R
MFP[B(<7=T/ 2CO-B@)@S2(*^"3!^/\P,A\G.)6^18I#R$H^V:^%%4B:$
MZ''+3I@Z!;GVC-7&CE67L%N@9"??0"[G7W6H?D JT.C>NUO>QW1&6FD$EKGS
M[:L>)SX8%@X90PTW7G#F$3].[)KVG]T0W7O9M@ J/M4=*CKXOP4Y%D"P707K
MU]3#GB>5,:IF3L$!P$##CT#$GMXNZ%T84H"OFU:\M2K&P?!#[B98=RCMB"^^
M?3TB(3COZT T:@#Q.@!M:1*9UB,(&1R,/^2F]4*'8/N;2JRK/FG&I<(B(9#]
MM>(
;96BC/7O(B#0>=@6*8I<]D'
M$EJQ(NE,DWORQ,)#C"?!=()>^@GRT0/.% Q3_RZ_'NM/"+E1$#[B),4U9IL-
MMA7@+B-Q63NI9#M
_(# DF86N&=(F";/1@X_2V8].C!$L=FR!5#*]K@NS\C 95ILT)DO5X
MAGB";#^O87TP;S^LP>RMY0ERAT6]A0=+5L>F2YD@-;.-(M^1"1),PM8$Z1(%
MV>C!QND=QR9("98Z-D&J&%[3!-G]O3FJ3(L3)/.5.< FZ\([=+:'\X47Z)C]
MM3M%%DI0-V\6W_9;':LN8Y+4S3B*?#
-
M[74Q5:"14VCF%3*QZLY52Z"V_2JF7)-1,$L),.WH6QZ6NEMTDFDA[/.3M'"TX0W.7PJ8#T#8F6!VSQ3;N;I# MJMB
MW.Z YE,&,[6!:5I&FC<'
M7U?]8+._L*H!IX%S\+56#2P[#*L:<)HX!U]KU<"RQZ"J0:>1<_!U5@TNNUQ7
M:CFG=$>PFE0^^.\].9W3>:C$,@^ZR2XWV>4FN]QDEYOLLE(IVB:[W&27F^QR
MDUUNLLNU9)=%2G3=("N8^@C$F\I'%?+5UZ!@G"HFKH##=S;$ ^C!FJ&@ZW9L
M['/83U,R:H*\)U,@_-D 7U,E2_[0H=4L-U$C^LBFSFC#Z77F+DZ4EZQ;IIG:
MIAPI ;- #X,"*D?E"9W8D/=SPY*',"1J !PKH5" /6A>5,H10@63*LD((!'8Z
M< .Z^DNM3%ZH5.)9%"FAHLOH#5AY8DQM1*$<4"DJK(&Q9D:[!"G:FDG17DHA
MGLZ0E^*P!"D.-9/B<"E%U1M"4F:0VI_04AAU7O K( 7A@!;T%D\?!]
ILYAO4FGAMX/AU;'KDDLS>=3#Q?^O#?EJUI-*=R2:/*5E?:8O4%#NO-J/V4
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M&IXF]!LI^BL\DI"QP@2FW]2%?C-%?X4Q>\8*Z5(1:WB:T-].T5]A98&,%0?
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M#>"HU] EZC524:]96]1K $>]ABY1KY&*>LW:HEX#..HU=(EZC534:]86]1K
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ML:5F4?NW7@<-IGU"U*7GDXL[+V83Y 8H>+!F\G
Label | Element | Value |
---|---|---|
Risk/Return: | rr_RiskReturnAbstract | |
Prospectus Date | rr_ProspectusDate | Jun. 30, 2019 |